Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes

International Journal of Antimicrobial Agents

Volumn 24, Issue 1, 2004, Pages 39-42

  Şener, Burçin ^a   Köseoǧlu, Özgen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Erythromycin A; Linezolid; Quinupristin dalfopristin; Telithromycin

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; LINEZOLID; MACROLIDE; PENICILLIN G; QUINUPRISTIN; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DRUG ACTIVITY; DRUG MECHANISM; GENE EXPRESSION; GENETIC MARKER; GENOTYPE; INFECTION SENSITIVITY; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TECHNIQUE;

DRUG RESISTANCE, MICROBIAL; GENOTYPE; MICROBIAL SENSITIVITY TESTS; PENICILLINS; RIBOSOMES; STREPTOCOCCUS PNEUMONIAE;

EID: 18544412061     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.11.009     Document Type: Article

References (30)

1. Klugman K.P. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:1990;171-196
2. Baquero F., Garcia-Rodriquez J.A., DeLomas J.G. Aguilar L and the Spanish surveillance group for respiratory pathogens. Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1 year (1996-1997) multicenter surveillance study. Antimicrob. Agents Chemother. 43:1999;357-359
3. Doern G.V., Pfaller M.A., Klugler K., Freeman J., Jones R.N. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance programme. Clin. Infect. Dis. 27:1998;764-770
4. Amsden G.W. Pneumococcal macrolide resistance: myth or reality? J. Antimicrob. Chemother. 44:1999;1-6
5. Leclerq R., Courvalin P. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:2002;2727-2734
6. Doern G.V., Heilmann K.P., Huynh H.K., Rhomberg P.R., Coffman S.L., Brueggemann A.B. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:2001;1721-1729
7. Weisblum B. Resistance to macrolide-lincosamide-streptogramin antibiotics. In: Fischetti V, editor. Gram positive pathogens. Washington, DC, USA: ASM Press, 2000, p. 694-710.
8. Oster P., Zanchi A., Cresti S., et al. Patterns of macrolide resistance determinants among community acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43:1999;2510-2512
9. Fitoussi F., Doit C., Geslin P., Brahimi N., Bingen E. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob. Agents Chemother. 45:2001;636-638
10. Johnston N.J., Azavedo J.C., Kellner J.D., Low D.E. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:1998;2425-2426
11. Hoban D.J., Wierzbowski A.K., Nichol K., Zhanel G.G. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45:2001;2147-2150
12. Bryskier A. New research in macrolides and ketolides since 1997. Expert Opin. Investig. Drug. 8:1999;1171-1194
13. Norrby R. Linezolid - a review of the first oxazolidinone. Expert Opin. Pharmacother. 2:2001;293-302
14. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, fifth ed. Wayne, PA, USA: NCCLS, 2000.
15. Waites K., Johnson C., Gray B., Edwards K., Crain M., Benjamin W. Jr. Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J. Clin. Microbiol. 38:2000;1731-1734
16. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:1996;2562-2566
17. Carbon C., Poole M.D. The role of newer macrolides in the treatment of community acquired respiratory tract infection: a review of experimental and clinical data. J. Chemother. 11:1999;107-118
18. Nilius A.M., Ma Z. Ketolides: the future of the macrolides. Curr. Opin. Pharmacol. 2:2002;1-8
19. Zurenko G.E., Yagý B.H., Schaadt R.D. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:1996;839-845
20. Barry A.L., Fuchs P.C., Brown S.D. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrob. Agents Chemother. 42:1998;945-946
21. Şener B., Günalp A. Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital. J. Antimicrob. Chemother. 42:1998;381-384
22. Gür D., Güçiz B., Hasçelik G., et al. Streptococcus pneumoniae penicillin resistance in Turkey. J. Chemother. 13:2001;541-545
23. Song J.H., Yang J.W., Peck K.R., et al. Spread of multidrug resistant Streptococcus pneumoniae in South Korea. Clin. Infect. Dis. 25:1997;747-749
24. Morosini M.I., Canton R., Loza E., et al. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms. Antimicrob. Agents Chemother. 45:2001;2427-2431
25. Figueriedo A.M.S., Austrian R., Urbaskova P., Teixeira L.A., Tomasz A. Novel penicillin resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. Microbial. Drug Resist. 1:1995;71-78
26. Setchanova L., Tomasz A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria. J. Clin. Microbiol. 37:1999;638-648
27. Kozlov R.S., Bogdanovitch T.M., Appelbaum P.C., et al. Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia. Antimicrob. Agents Chemother. 46:2002;2963-2968
28. Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with longacting macrolide consumption. J. Chemother. 11(Suppl 1):1999;35-43
29. Pankuch G.A., Visalli M.A., Jacobs M.R., Appelbaum P.C. Susceptibilities of penicillin and erythromycin susceptible and resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. Antimicrob. Agents Chemother. 42:1998;624-630
30. Fuchs P.C., Barry A.L., Brown S.D. In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime. J. Antimicrob. Chemother. 49:2002;399-401